DrugsControl Media Services

News Detail

Delhi HC bars Natco Pharma from selling cancer drug Olaparib (05-03-2024)

New Delhi, 5 March 2024: The Delhi High Court has barred Natco Pharma from manufacturing and selling cancer drug Olaparib either under the brand name ‘BRACANAT’ or under other brand names till further orders.

“…the defendant (Natco) is in fact ......
View Details

Source : DrugsControl Media Services
Natco Pharma natco pharma Delhi Delhi High Court cancer drug Olaparib BRACANAT brand names Patents Act infringement

Related News